Cargando…

Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions

Metabolic syndrome (MetS) is a well-recognized cluster of cardiovascular (CV) risk factors including obesity, hypertension, dyslipidemia, and hyperglycaemia, closely associated with an increased risk of forthcoming cardiovascular disease and type 2 diabetes mellitus. Emerging evidence indicates that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corona, Giovanni, Vignozzi, Linda, Rastrelli, Giulia, Lotti, Francesco, Cipriani, Sarah, Maggi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943333/ https://www.ncbi.nlm.nih.gov/pubmed/24688539 http://dx.doi.org/10.1155/2014/329456

Ejemplares similares

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019)

Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
por: Corona, Giovanni, et al.
Publicado: (2014)

Metabolic syndrome and prostate abnormalities in male subjects of infertile couples
por: Lotti, Francesco, et al.
Publicado: (2014)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
por: Gacci, Mauro, et al.
Publicado: (2013)

Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
por: Corona, Giovanni, et al.
Publicado: (2022)

Erectile dysfunction and central obesity: an Italian perspective
por: Corona, Giovanni, et al.
Publicado: (2014)

Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
por: Yannas, Dimitri, et al.
Publicado: (2021)

Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial
por: Rastrelli, G., et al.
Publicado: (2022)

Treatment of Functional Hypogonadism Besides Pharmacological Substitution
por: Corona, Giovanni, et al.
Publicado: (2020)

Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction
por: Rastrelli, Giulia, et al.
Publicado: (2019)

SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction
por: Di Stasi, Vincenza, et al.
Publicado: (2021)

Male Sexual Dysfunctions in the Infertile Couple–Recommendations From the European Society of Sexual Medicine (ESSM)
por: Capogrosso, Paolo, et al.
Publicado: (2021)

Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction
por: Cipriani, S., et al.
Publicado: (2021)

Biochemical predictors of structural hypothalamus–pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism
por: Cipriani, S., et al.
Publicado: (2021)

The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia
por: Gandhi, Jason, et al.
Publicado: (2017)

Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males
por: Corona, Giovanni, et al.
Publicado: (2021)

Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2017)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
por: Shin, Yu Seob, et al.
Publicado: (2019)

The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2016)

The role of testosterone in male sexual function
por: Corona, Giovanni, et al.
Publicado: (2022)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
por: Oka, Anak Agung Gde, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study
por: Gacci, Mauro, et al.
Publicado: (2017)

Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion
por: Corona, Giovanni, et al.
Publicado: (2013)

Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia
por: Carmignani, Luca, et al.
Publicado: (2015)

Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021)

Erectile dysfunction in fit and healthy young men: psychological or pathological?
por: Rastrelli, Giulia, et al.
Publicado: (2017)

Prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research : an update
Publicado: (2003)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
por: Qalawena, Muhammed M., et al.
Publicado: (2020)

Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia
por: Tian, Ye, et al.
Publicado: (2020)

Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
por: Kosilov, Kirill V., et al.
Publicado: (2020)

Correlation between Cholinergic Innervation, Autophagy, and Etiopathology of Benign Prostatic Hyperplasia
por: Cai, Jian-Liang, et al.
Publicado: (2017)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee, Wei-Chang, et al.
Publicado: (2013)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iqv3bmea2gcd87a8q4p70ebas3